Swindon, United Kingdom

Craig Wheadon


 

Average Co-Inventor Count = 4.5

ph-index = 4

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: **Innovative Approaches in Pharmaceutical Science: The Contributions of Craig Wheadon**

Introduction

Craig Wheadon, an esteemed inventor based in Swindon, GB, has made significant advancements in the pharmaceutical industry. With a total of eight patents to his name, he has focused on innovative solutions to enhance drug formulations, particularly in stabilizing pharmaceutical products during storage.

Latest Patents

Among his latest patents is a method for minimizing agglomeration of drug particle coating material during storage, which aims to stabilize disintegration times of pharmaceutical products. This invention encompasses pharmaceutical compositions and methods for preparing these compositions using solventless mixing techniques. One notable aspect is the sieving process that allows for the removal of excess unbound coating material from coated active pharmaceutical ingredients (API). Wheadon’s work optimizes coating and dosing ratios to limit the amount of excess unbound coating material, thereby reducing agglomeration during storage. Specifically, he has formulated a pharmaceutical composition that includes 65-85% w/w API particles, 15-30% w/w coating material, and 3-15% w/w matrix, achieving a disintegration time rate of less than 10 seconds for at least six months under conditions of 25° C and 60% relative humidity.

Career Highlights

Currently, Wheadon is associated with Catalent UK Swindon Zydis Limited, where his research and innovations continue to influence the field of pharmaceuticals. His work not only advances the science of drug formulation but also contributes to the efficiency and effectiveness of pharmaceutical delivery systems worldwide.

Collaborations

Craig Wheadon collaborates with notable colleagues such as Rosaleen McLaughlin and Simon Andrew Martyn Howes, pooling their expertise to further innovate pharmaceutical compositions. Their collective efforts have led to significant advancements in drug delivery methodologies, showcasing the importance of teamwork in scientific progress.

Conclusion

In conclusion, Craig Wheadon’s contributions to the pharmaceutical industry through his innovative patents have positioned him as a valuable inventor in the field. His focus on optimizing drug formulations not only enhances product stability but also demonstrates the continuous evolution of pharmaceutical science, making a lasting impact on healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…